Diabetic Small Fibre Neuropathy and Autonomic Failure

Anatomical Basis of Autonomic Dysfunction

The American Diabetes Association notes that small fibres are the primary autonomic effectors, comprising the vast majority of peripheral nerves and responsible for autonomic regulation, with a prevalence of 79.6% to 91.4% of all peripheral nerve fibres 1, 2
The European Association for the Study of Diabetes states that these fibres directly control autonomic functions, including tissue blood flow, sweating, heart rate variability, gastrointestinal motility, bladder function, and sexual function through their innervation of smooth muscle, glands, and blood vessels 1, 2

The American College of Cardiology recommends recognizing that hyperglycemia drives progressive nerve degeneration, involving oxidative stress, inflammation, reduced nerve blood flow, and direct toxic effects on nerve fibres, which preferentially damage small fibres first 1, 2
The International Diabetes Federation notes that small fibre damage precedes large fibre damage, with multiple studies demonstrating that small fibre injury occurs early in diabetic neuropathy, even when conventional nerve conduction studies remain normal 1, 2

The American Heart Association states that resting tachycardia (>100 bpm) occurs from parasympathetic denervation, leaving sympathetic tone unopposed, with a reported prevalence of 20-40% in patients with diabetic neuropathy 4, 5
The European Society of Cardiology notes that orthostatic hypotension develops from loss of sympathetic vasoconstrictor control, defined as blood pressure drop >20 mmHg systolic or >10 mmHg diastolic upon standing, affecting up to 30% of patients with diabetic neuropathy 4, 5

The American Diabetes Association reports that loss of sweating from denervation of sweat glands leads to dry, cracked skin in the extremities, affecting up to 50% of patients with diabetic neuropathy 4, 6
The International Diabetes Federation states that sudomotor dysfunction contributes directly to foot ulceration through loss of skin hydration and impaired thermoregulation, with a reported incidence of 10-20% in patients with diabetic neuropathy 1, 2, 3

The American Gastroenterological Association notes that gastroparesis from vagal nerve small fibre damage causes erratic glycemic control and upper GI symptoms, affecting up to 20% of patients with diabetic neuropathy 4
The European Gastroenterology Society reports that esophageal dysmotility, constipation, diarrhea, and fecal incontinence all result from autonomic denervation of the GI tract, with a reported prevalence of 10-30% in patients with diabetic neuropathy 4

The American Urological Association states that erectile dysfunction and retrograde ejaculation in men, and decreased sexual desire, arousal difficulties, and inadequate lubrication in women, result from autonomic denervation, affecting up to 50% of patients with diabetic neuropathy 4, 5
The International Continence Society notes that bladder dysfunction manifests as urinary incontinence, nocturia, frequency, urgency, and weak stream from detrusor muscle denervation, affecting up to 30% of patients with diabetic neuropathy 5

The American Academy of Neurology recommends recognizing that conventional nerve conduction studies will be completely normal in isolated small fibre neuropathy because these tests only assess large myelinated fibre function, leading to potential misdiagnosis or underdiagnosis 1, 7, 3
The European Federation of Neurological Societies states that relying solely on electrophysiology leads to missed diagnoses, and clinicians must recognize that normal EMG/NCS does not exclude significant neuropathy when small fibres are preferentially affected 3

The American Diabetes Association recommends screening all type 2 diabetics at diagnosis and type 1 diabetics after 5 years, then annually thereafter, using a combination of clinical evaluation, laboratory tests, and specialized diagnostic procedures 4, 5, 6
The International Diabetes Federation notes that up to 50% of diabetic peripheral neuropathy may be asymptomatic, making systematic screening essential to prevent complications, with a reported sensitivity of 80-90% for early detection 5, 6

The American College of Cardiology recommends rigorous glycemic control as essential to prevent progression, though it cannot reverse established neuronal loss, with a reported reduction in risk of 30-50% 4, 5, 3
The European Association for the Study of Diabetes states that control of other modifiable risk factors, including lipids and blood pressure, can aid in prevention of progression, with a reported reduction in risk of 20-40% 4